Cargando…
Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer’s disease risk
Clusterin (CLU) is an extracellular chaperone involved in reducing amyloid beta (Aβ) toxicity and aggregation. Although previous genome-wide association studies (GWAS) have reported a potential protective effect of CLU on Alzheimer’s disease (AD) patients, how intron-located rs11136000 (CLU) affects...
Autores principales: | Ma, Jin, Qiu, Shizheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407972/ https://www.ncbi.nlm.nih.gov/pubmed/36033622 http://dx.doi.org/10.3389/fnins.2022.926830 |
Ejemplares similares
-
Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
por: Cai, Rongrong, et al.
Publicado: (2016) -
Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: A review and meta-analysis of case-control studies
por: Du, Wenjin, et al.
Publicado: (2016) -
Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer’s Disease in Caucasian But Not Chinese population
por: Han, Zhijie, et al.
Publicado: (2018) -
Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
por: Ling, I-Fang, et al.
Publicado: (2012) -
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019)